Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
Description
Ionizable lipid nanoparticles (LNPs) have gained attention as mRNA delivery platforms for vaccination against COVID-19 and for protein replacement therapies. LNPs enhance mRNA stability, circulation time, cellular uptake, and preferential delivery to
